FDA Panel Endorses Wider Use of Breast Cancer Drug

Source: HealthDay

Sep 13, 2013

U.S. advisers endorsed the broader use of a drug already used to treat advanced breast cancer that also appears to shrink early stage breast tumors.

This could potentially offer women with early stage breast cancer a first-of-its-kind treatment option and the hope of less-invasive surgical procedures. Read the full story.